Mammograms Specialist Albany OR

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer.

Bruce E Frey
(541) 768-5220
501 Nw Elks Dr
Corvallis, OR
Specialty
Radiation Oncology

Data Provided by:
Patrice McGowan
(541) 768-5220
501 Nw Elks Dr
Corvallis, OR
Specialty
Radiation Oncology

Data Provided by:
Dr.Peter Kenyon
(541) 754-1150
Suite 161, 3640 Northwest Samaritan Drive
Corvallis, OR
Gender
M
Education
Medical School: Univ Of Pa Sch Of Med
Year of Graduation: 1975
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
4.8, out of 5 based on 3, reviews.

Data Provided by:
Mary M Austin-Seymour
(541) 768-5220
501 Nw Elks Dr
Corvallis, OR
Specialty
Radiation Oncology

Data Provided by:
Peter D Kenyon
(541) 754-1150
3680 Nw Samaritan Dr
Corvallis, OR
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Xinyu Steve Fu
(541) 754-1150
3680 Nw Samaritan Dr
Corvallis, OR
Specialty
Hematology

Data Provided by:
David T Huang, MD
(804) 828-7232
Corvallis, OR
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1987

Data Provided by:
Michael Owen Huntington, MD
(208) 523-8126
3600 NW Samaritan Dr
Corvallis, OR
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Mo, Columbia Sch Of Med, Columbia Mo 65212
Graduation Year: 1973

Data Provided by:
Howard Wayne Fellows, MD
(541) 754-1256
3680 NW Samaritan Dr
Corvallis, OR
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Creighton Univ Sch Of Med, Omaha Ne 68178
Graduation Year: 1988

Data Provided by:
Vicky H Lee
(541) 754-1150
3680 Nw Samaritan Dr
Corvallis, OR
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Mandatory Mammograms

Provided by: 

By Vonalda M. Utterback, CN

“Time to make breast pancakes,” says one friend of mine, referring to her scheduled mammography screening. And although she may crack jokes about the experience, she’s never once questioned the need for her annual pilgrimage, nor has her physician discussed the risks versus the benefits it entails. After all, if you are a woman aged 40 or beyond, yearly mammograms are simply de rigueur.

When your doctor refers you for a screening, he or she is likely following the guidelines of the two leading national cancer research and information organizations primarily responsible for setting public health policy on cancer screening: The private American Cancer Society (ACS) and the government’s National Cancer Institute (NCI). Both, along with other well-funded, high-profile organizations, such as Susan G. Komen for the Cure, recommend regular mammogram screening of symptom-free women beginning at age 40.

All this official blessing shouldn’t make regular screening mammography sacrosanct, however. In fact, it’s way past time for women to start asking hard questions about the exam’s efficacy and its potential harm, say many women’s health experts, advocates, and researchers. “Screening mammography is clearly a double-edged sword,” explains Lisa Schwartz, MD, co-director of the Veteran’s Administration Outcomes Group in White River Junction, Vermont, and associate professor of medicine at Dartmouth Medical School.

False truths
According to the National Academy of Sciences 2005 publication, Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis, the risk of a false-positive result in a mammogram is about 1 in 10. About three-quarters of the resulting biopsies turn out to be benign, it’s true, but to learn that a woman has to endure the fear that she has breast cancer and bear the cost, discomfort, and risk of additional medical procedures.

“Regular screening will save some lives, but it will cause even more women to be harmed through the unnecessary diagnosis and treatment of cancer that would never have affected their health, were it not for screening,” says Schwartz. She’s referring to false-positives associated with “ductal carcinoma in situ” (DCIS), a result that many experts consider one of the most harmful risks associated with screening mammography.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer. “Most women with DCIS will be advised to undergo invasive treatment of unknown benefit, such as lumpectomy combined with radiation,” reports Schwartz.
Harm from over-diagnosis of invasive cancer also may occur because many malignant cancers grow quite slowly, says Peter C. Gotzsche, MD, r...

Author: Vonalda M. Utterback, CN

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...